Carsten Helleberg

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Journal: British journal of haematology

Published: February 20, 2026

Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.

Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: May 30, 2024

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Journal: Blood cancer journal

Published: December 20, 2023

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

Journal: EJHaem

Published: July 13, 2023

Potential value of pre-planned imaging of bone disease in multiple myeloma.

Potential value of pre-planned imaging of bone disease in multiple myeloma.

Journal: Blood cancer journal

Published: December 06, 2022

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.

Journal: BMC cancer

Published: October 05, 2021

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

Journal: American journal of hematology

Published: September 10, 2021

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.

Journal: European journal of haematology

Published: June 12, 2021

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Journal: Hematological oncology

Published: June 11, 2021

The real-world outcomes of multiple myeloma patients treated with daratumumab.

The real-world outcomes of multiple myeloma patients treated with daratumumab.

Journal: PloS one

Published: March 19, 2021

Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.

Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.

Journal: Blood cancer journal

Published: December 10, 2020

Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.

Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: October 19, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026